These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6182407)

  • 41. Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.
    Jugdutt BI; Hutchins GM; Bulkley BH; Becker LC
    Circ Res; 1981 Sep; 49(3):685-700. PubMed ID: 7020976
    [No Abstract]   [Full Text] [Related]  

  • 42. Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis.
    Romson JL; Hook BG; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):288-94. PubMed ID: 6313894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).
    Orchard MA; Ritter JM; Shepherd GL; Lewis PJ
    Br J Clin Pharmacol; 1983 May; 15(5):509-11. PubMed ID: 6344895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostacyclin therapy in patients with congestive heart failure.
    Yui Y; Nakajima H; Kawai C; Murakami T
    Am J Cardiol; 1982 Aug; 50(2):320-4. PubMed ID: 7048886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
    Hyman AL; Kadowitz PJ
    Circ Res; 1979 Sep; 45(3):404-9. PubMed ID: 110490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cicletanide improves outcome after left circumflex coronary artery occlusion-reperfusion in the dog.
    Jouve R; Langlet F; Puddu PE; Rolland PH; Guillen JC; Cano JP; Serradimigni A
    J Cardiovasc Pharmacol; 1986; 8(1):208-15. PubMed ID: 2419686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.
    Casals-Stenzel J; Buse M; Losert W
    Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
    Szekeres L; Krassói I; Pataricza J; Udvary E
    Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemodynamic changes induced by prostacyclin in man.
    Szczeklik J; Szczeklik A; Nizankowski R
    Br Heart J; 1980 Sep; 44(3):254-8. PubMed ID: 7000101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of prostacyclin (PGI2) on hypoxic pulmonary vasoconstriction in the conscious adult sheep.
    Kubo K; Kobayashi T; Kusama S; Sakai A; Ueda G
    Jpn Circ J; 1985 Jul; 49(7):685-91. PubMed ID: 3903240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of prostacyclin on vascular capacity in the dog.
    Fulghum TG; DiMarco JP; Supple EW; Nash I; Gendlerman J; Eton DF; Newell JB; Zusman RM; Powell WJ
    J Clin Invest; 1985 Sep; 76(3):999-1006. PubMed ID: 3930573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease.
    Bergman G; Daly K; Atkinson L; Rothman M; Richardson PJ; Jackson G; Jewitt DE
    Lancet; 1981 Mar; 1(8220 Pt 1):569-72. PubMed ID: 6110816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction between prostacyclin and nitric oxide in the reflex control of the coronary circulation in conscious dogs.
    Zhao G; Xu X; Ochoa M; Shen W; Hintze TH
    Cardiovasc Res; 1996 Nov; 32(5):940-8. PubMed ID: 8944825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Some direct and reflex cardiovascular actions of prostacyclin (PGI2) and prostaglandin E2 in anaesthetized dogs.
    Chapple DJ; Dusting GJ; Hughes R; Vane JR
    Br J Pharmacol; 1980 Mar; 68(3):437-47. PubMed ID: 6762901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size.
    Jugdutt BI
    Prostaglandins Med; 1981 Nov; 7(5):431-55. PubMed ID: 6798589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction.
    Melin JA; Becker LC
    J Am Coll Cardiol; 1983 Aug; 2(2):279-86. PubMed ID: 6345632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epoprostenol (PGI2) reduces the incidence of post-reperfusion ventricular fibrillation in the dog.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Serradimigni A
    Cardiologia; 1985 Feb; 30(2):91-7. PubMed ID: 3905005
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiovascular and electrophysiological analysis of a selective vasodilatory prostacyclin analogue, 5-nitro-PGI1.
    Kecskeméti V; Stadler I; Körmöczy P
    Biomed Biochim Acta; 1984; 43(8-9):S287-90. PubMed ID: 6440542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosis.
    Kowey PR; Verrier RL; Lown B; Handin RI
    Am J Cardiol; 1983 Feb; 51(3):596-602. PubMed ID: 6186137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.